Emcure Pharmaceuticals Ltd., a leading Indian pharmaceutical company, and its subsidiary, Gennova Biopharmaceuticals Limited, have signed a 22.78 MWp DC Solar Power Purchase Agreement (PPA) with Sunsure Energy, a major renewable power producer in India. This partnership will provide Emcure and Gennova with approximately 36 million kWh of clean energy annually for their Pune plants. According to Emcure, this deal will fulfill around 67% of their power needs with green energy and reduce CO2 emissions by 29,765.71 metric tons per year. As part of the PPA, Emcure and Gennova will acquire a stake in Sunsure Solarpark Twelve Private Limited, under a group captive scheme in accordance with the Electricity Act, 2023. Sunsure will supply the power from its 150 MWp DC solar plant in Solapur, Maharashtra.
Emcure signs 22.78 MWp solar power agreement
Emcure and Gennova will acquire a stake in Sunsure Solarpark Twelve Private Limited as part of the agreement. (Image Credit: Pixabay)
Aiming to support Malaysia’s 31% renewable goal by 2025, Masdar’s study could pave the way for large-scale floating solar in Southeast Asia. (Image Source: Masdar)
Avangrid’s Camino Solar project will generate power for approximately 14,000 US homes and is expected to create $15 million in local tax revenue. (Image Source: Avangrid)
Poland’s solar sector is set to benefit from Suntech’s advanced TOPCon modules under a new 200 MW distribution partnership. (Image Source: Suntech/ Linkedin)
Telecrown’s order from RRP Semiconductor includes silicon solar cells and polycrystalline materials for Maharashtra’s growing renewable energy sector. (Image Credit/Source: fietzfotos/Pixabay)